| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/04/2003 | WO2003045313A3 2-aminoquinoline compounds |
| 09/04/2003 | WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 09/04/2003 | WO2003028730A3 Pharmaceutical combinations of pde-v inhibitors and other agents |
| 09/04/2003 | WO2002068387A8 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166910 Bone morphogenic protein |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166847 Novel human leptin receptor gene-related protein |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |
| 09/04/2003 | US20030166661 Administering a synergistic mixture of L-arginine and a type V phosphodiesterase enzyme inhibitor as an antispasmodic agent to induce vasodilation; treating of cardiac pathologies as well as sexual disorders such as erectile dysfunction |
| 09/04/2003 | US20030166655 Acyclic nucleotide phosphodiesterase of type 4 inhibitors; antiinflammatory agents; antiallergens; antiarthritis agents, rheumatic diseases; AIDS; gastrointestinal, respiratory, brain, urogenital disorders |
| 09/04/2003 | US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 09/04/2003 | US20030166641 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166628 Drugs such as 3-(4-chlorobenzo(b)thiophen-2-yl)-5,6-dihydro-imidazo(2,1-b)thiazole, used as hydroxytryptamine and/or noradrenaline reuptake inhibitors; anxiolytic agents |
| 09/04/2003 | US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/04/2003 | US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents |
| 09/04/2003 | US20030165506 Novel alpha-catenin expressed in heart and testis |
| 09/04/2003 | US20030165478 Stabilized synthetic immunogen delivery system |
| 09/04/2003 | CA2477245A1 Bipolar trans carotenoid salts and their uses |
| 09/04/2003 | CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| 09/04/2003 | CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders |
| 09/04/2003 | CA2477008A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | CA2476173A1 Arylsulfone derivatives |
| 09/03/2003 | EP1340979A2 Neuropeptide receptor and uses thereof |
| 09/03/2003 | EP1339866A2 Human testis specific serine/threonine kinase |
| 09/03/2003 | EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof |
| 09/03/2003 | EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/03/2003 | EP1339834A2 Enzymes |
| 09/03/2003 | EP1339717A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339715A2 Heterocyclic ether substituted imidazoquinolines |
| 09/03/2003 | EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 09/03/2003 | EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 09/03/2003 | EP1339683A2 Estrogen receptor modulators |
| 09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 09/03/2003 | EP1339662A1 Novel estrogen receptor ligands and methods iii |
| 09/03/2003 | EP1339425A2 Vaccine composition containing transforming growth factor alpha |
| 09/03/2003 | EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 09/03/2003 | EP1339415A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 09/03/2003 | EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines |
| 09/03/2003 | EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 09/03/2003 | EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases |
| 09/03/2003 | EP1095038B1 Antagonists of gonadotropin releasing hormone |
| 09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
| 09/03/2003 | EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 09/03/2003 | EP0767798B1 Sterol derivatives used for regulation of meiosis |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 09/03/2003 | CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 09/03/2003 | CN1440406A 黑皮质素受体配体 Melanocortin receptor ligands |
| 09/03/2003 | CN1440396A Colchinol derivatives as angiogenesis inhibitors |
| 09/03/2003 | CN1440395A COLCHINOL derivatives as vascular damaging agents |
| 09/03/2003 | CN1440283A Combination of organic compounds |
| 09/03/2003 | CN1439673A High friction coefficient rubber composite brake shoes |
| 09/03/2003 | CN1439420A Oral Chinese medicinal contraceptive medicine |
| 09/03/2003 | CN1439416A Agent for protecting womb from profuse menstuation and its preparing method |
| 09/03/2003 | CN1439397A Medicine for menstrual disorder and leukorrhagia |
| 09/03/2003 | CN1439381A Separating method, medicinal use and preparation of medicinal components of anaerobic corynebacterium parvum |
| 09/03/2003 | CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems |
| 09/03/2003 | CN1439370A Matrine vaginal effervescent tablets |
| 09/03/2003 | CN1439367A Pratensein extraction and preparation thereof |
| 09/03/2003 | CN1120162C Novel benzopyran derivatives |
| 09/03/2003 | CN1120009C Chinese medicine ÔÇ£Ruan capsuleÔÇØ for treating mastoplasia |
| 09/03/2003 | CN1120007C Medicine for treating mastopathy |
| 09/03/2003 | CN1120004C Coated gongyanping tablet in special shape and its making process |
| 09/03/2003 | CN1119999C Oral contraceptive |
| 09/02/2003 | US6613913 Intermediate for antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1, 6,9-trioxa-3-aza-cyclopenta [a]naphthalene |
| 09/02/2003 | US6613891 Polynucleotides that encode bovine inhibin |
| 09/02/2003 | US6613874 Melanocortin receptor ligands |
| 09/02/2003 | US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/02/2003 | US6613801 Method for the synthesis of compounds of formula I and their uses thereof |
| 09/02/2003 | US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/02/2003 | US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 09/02/2003 | US6613768 Treatment of female arousal disorder |
| 09/02/2003 | US6613757 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 09/02/2003 | US6613737 Fractionating serum/blood plasma by chromatography and electrophoresis; sperm-motility promoting glycoprotein |
| 09/02/2003 | US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine |
| 08/28/2003 | WO2003070910A2 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070751A2 Partial peptide mimetics and methods |
| 08/28/2003 | WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 08/28/2003 | WO2003070730A1 Pyrrolopyrimidine derivative |
| 08/28/2003 | WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation |
| 08/28/2003 | WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 08/28/2003 | WO2003070281A1 Prostaglandin composition for the treatment of erectile dysfunction |
| 08/28/2003 | WO2003070262A1 Pharmacological composition based on biologically active substances obtained from tribulus terrestris l |
| 08/28/2003 | WO2003070255A1 Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12 |
| 08/28/2003 | WO2003070253A1 Estrogenic component for treating decreased libido in women |